Her2-neu score 0 predicts poor survival in patients with triple-negative breast cancer

Purpose: Many patients with triple-negative breast cancer (TNBC) have a poor outcome, but not all of them. Now the question arises why patients with TNBC have so different individual courses of disease. The present study was perfomed in order to distinguish the survival from patients with HER2neu Score 0 and HER2neu Score 1 and 2 with negative FISH. Experimental Design: Retrospectively, we studied a cohort of 133 patients with TNBC, diagnosed at the Saarland University Medical Center between December 2004 and June 2013. We compared the disease-free survival (DFS) and overall survival (OS) in those women on the b…